Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.59 |
| ▸ | TLR7 | Q9NYK1 | 4/20 | 0.59 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.55 |
| ▸ | CLK2 | P49760 | 4/20 | 0.55 |
| ▸ | CLK3 | P49761 | 4/20 | 0.55 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.54 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.54 |
| ▸ | JAK2 | O60674 | 1/20 | 0.54 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.54 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.54 |
| ▸ | PAK4 | O96013 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29216254 | 0.93 | TLR8 (0.57) | TLR8TLR7TLR9ALDH1A1CYP1A2 | |
| SCHEMBL29966067 | 0.83 | CYP11B1 (0.56) | TLR8TLR7TLR9ALDH1A1CYP1A2 | |
| SCHEMBL16610292 | 0.82 | MAPT (0.63) | TLR8TLR7TLR9ALDH1A1CYP1A2 | |
| SCHEMBL6123307 | 0.81 | MAOA (0.55) | TLR8TLR7TLR9ALDH1A1CYP1A2 | |
| SCHEMBL18135487 | 0.80 | CHUK (0.64) | ALDH1A1AURKAJAK2PIM1MKNK1 | |
| SCHEMBL20009913 | 0.79 | TLR8 (0.46) | TLR8TLR7TLR9CYP2A6DYRK1A | |
| SCHEMBL2552499 | 0.79 | KDM4E (0.53) | TLR8TLR7TLR9CYP3A4DYRK1A | |
| SCHEMBL12868091 | 0.79 | SIRT2 (0.50) | TLR8TLR7TLR9DYRK1ACLK2 | |
| SCHEMBL21834364 | 0.79 | PDE10A (0.62) | TLR8TLR7TLR9DYRK1ACLK2 | |
| SCHEMBL10213963 | 0.78 | JAK2 (0.69) | DYRK1ACLK2CLK3FGFR1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210143342-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AROMATIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-9705093-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-11 | — | — | US | disclosed |
| US-9705093-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-11 | — | — | US | disclosed |
| US-20140361268-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-12-11 | — | — | US | disclosed |
| US-20140361268-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210143342-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AROMATIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | CTCF, LEF1, BRD4 | TLR8 3206/4885TLR7 2308/4885TLR9 3135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.